EZH2 and breast cancer: It has been previously reported that CDK1 promotes the migration and metastasis of cancer cells, e.g., colorectal carcinoma and breast cancer cells, by phosphorylating proteins such as EZH2 and activating pathways such as the Wnt/β-Catenin and ERK/GSK3β/SNAI axes [71,72,73].